Human cells with acute myelocytic leukemia, shown with an esterase stain at 400x

Scientists develop new class of cancer drug with potential to treat leukaemia

26 April 2021

Scientists have made a promising step towards developing a new drug for treating acute myeloid leukaemia, a rare blood disorder. In a study published today in Nature, Cambridge researchers report a new approach to cancer treatment that targets enzymes which play a key role in translating DNA into proteins and which could lead to a new class of cancer drugs.

Read More

HeLa: the cells that changed science

25 February 2021

Discover the incredible story of Henrietta Lacks, an African American woman whose cells enabled a scientific revolution and contributed to numerous incredible developments and life-saving treatments in a special book club as part of the Cambridge Festival.

Read More

Set up for life

25 November 2020

We’re used to the idea that as adults we have some control over our destiny: what we eat and drink and how much we exercise can affect our health. But the risks of heart disease and diabetes can be programmed much earlier – even before we are born.

Read More
Coronavirus

Discovery of shape of the SARS-CoV-2 genome after infection could inform new COVID-19 treatments

05 November 2020

Scientists at the University of Cambridge, in collaboration with Justus-Liebig University, Germany, have uncovered how the genome of SARS-CoV-2 - the coronavirus that causes COVID-19 - uses genome origami to infect and replicate successfully inside host cells. This could inform the development of effective drugs that target specific parts of the virus genome, in the fight against COVID-19.

Read More

Pages